Phathom Pharmaceuticals Stock Price on July 25, 2025
| PHAT Stock | USD 11.78 0.12 1.03% |
If you're considering investing in Phathom Stock, it is important to understand the factors that can impact its price. As of today, the current price of Phathom Pharmaceuticals stands at 11.78, as last reported on the 26th of September, with the highest price reaching 11.95 and the lowest price hitting 11.31 during the day. Phathom Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Phathom Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Phathom Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Phathom Pharmaceuticals' Semi Deviation of 3.24, coefficient of variation of 974.51, and Risk Adjusted Performance of 0.0727 to confirm if our risk estimates are consistent with your expectations. Phathom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Related Headline
Arcutis Biotherapeutics Headline on 25th of July 2025
Goldman Sachs Initiates Coverage On Arcutis Biotherapeutics ... by gurufocus.com
On July 25, 2025, Goldman Sachs analyst Richard Law initiated coverage on Arcutis Biotherapeutics , assigning a Neutral rating. This marks the first rat
Phathom Pharmaceuticals Valuation on July 25, 2025
It is possible to determine the worth of Phathom Pharmaceuticals on a given historical date. On July 25, 2025 Phathom was worth 9.0 at the beginning of the trading date compared to the closed value of 9.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Phathom Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Phathom Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Phathom Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Phathom Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 8.47 | 9.15 | 8.27 | 9.05 | 1,020,830 | |
07/25/2025 | 9.00 | 9.71 | 8.83 | 9.63 | 1,667,032 |
| 9.63 | 10.03 | 8.80 | 8.80 | 1,050,267 |
| Backtest Phathom Pharmaceuticals | | | Phathom Pharmaceuticals History | | | Phathom Pharmaceuticals Valuation | Previous | Next |
Phathom Pharmaceuticals Trading Date Momentum on July 25, 2025
| On July 28 2025 Phathom Pharmaceuticals was traded for 8.80 at the closing time. The top price for the day was 10.03 and the lowest listed price was 8.80 . The trading volume for the day was 1.1 M. The trading history from July 28, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 8.62% . The trading delta at closing time against the current closing price is 13.08% . |
Phathom Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Phathom Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Phathom Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Phathom financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Phathom Pharmaceuticals Stock history
Phathom Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phathom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phathom Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phathom Pharmaceuticals stock prices may prove useful in developing a viable investing in Phathom Pharmaceuticals
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey. Phathom Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.
Phathom Pharmaceuticals Stock Technical Analysis
Phathom Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Phathom Pharmaceuticals Period Price Range
Low | September 26, 2025
| High |
0.00 | 0.00 |
Phathom Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Phathom Pharmaceuticals September 26, 2025 Market Strength
Market strength indicators help investors to evaluate how Phathom Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Phathom Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Phathom Pharmaceuticals stock market strength indicators, traders can identify Phathom Pharmaceuticals entry and exit signals to maximize returns
Phathom Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Phathom Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phathom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phathom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0727 | |||
| Jensen Alpha | 0.1934 | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.082 | |||
| Treynor Ratio | 0.2032 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.